Medtronic’s Emprint catheter kit receives FDA Breakthrough designation

Medtronic has received Breakthrough Device Designation status from the U.S. Food and Drug Administration (FDA) for the Emprint ablation catheter kit – an investigational device not yet approved or cleared in the United States.